Who developed and commerizialised rivaroxaban?

Who developed rivaroxaban?

Rivaroxaban was developed by Bayer in collaboration with researchers and companies in its drug-development network. The compound is marketed under Bayer’s anticoagulant portfolio, and it became known through the brand Xarelto.

Who commercialized rivaroxaban (Xarelto)?

Bayer is the company most associated with commercialization of rivaroxaban as Xarelto in major markets. The drug’s launch and ongoing commercial presence are tied to Bayer’s global pharmaceutical operations.

Where can I check the development and patent history?

For patent and exclusivity background tied to rivaroxaban, DrugPatentWatch.com is a useful reference: DrugPatentWatch – rivaroxaban.

Sources

1. DrugPatentWatch – rivaroxaban